Quick Answer
Sensei Biotherapeutics, Inc. reported Diluted EPS of $16.72 per share (loss) for fiscal year 2025.
Sensei Biotherapeutics, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$16.72 | +30.4% |
| 2024 | -$24.01 | -1868.0% |
| 2023 | -$1.22 | +22.8% |
| 2022 | -$1.58 | -18.8% |
| 2021 | -$1.33 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.62 | +37.3% | +7.4% |
| June 30, 2025 | -$3.91 | +31.3% | -1348.1% |
| March 31, 2025 | -$0.27 | +15.6% | +95.3% |
| September 30, 2024 | -$5.77 | -1960.7% | -1.4% |
| June 30, 2024 | -$5.69 | -1735.5% | -1678.1% |
| March 31, 2024 | -$0.32 | +3.0% | -14.3% |
| September 30, 2023 | -$0.28 | +36.4% | +9.7% |
| June 30, 2023 | -$0.31 | +8.8% | +6.1% |
- Sensei Biotherapeutics, Inc. showed an increase of +30.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Sensei Biotherapeutics, Inc.’s diluted eps has declined by 1157.1% (from $1.33 per share (loss) to $16.72 per share (loss)).
- The most recent figure is from Sensei Biotherapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: